Geneos Wealth Management’s First Trust Growth Strength ETF FTGS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$830K Sell
22,431
-49
-0.2% -$1.78K 0.02% 589
2026
Q1
$765K Buy
22,480
+544
+2% +$19.3K 0.02% 572
2025
Q4
$775K Buy
21,936
+1,680
+8% +$59.7K 0.02% 560
2025
Q3
$727K Sell
20,256
-526
-3% -$18.5K 0.02% 564
2025
Q2
$711K Buy
20,782
+11,041
+113% +$347K 0.02% 610
2025
Q1
$290K Buy
9,741
+2,379
+32% +$74.7K 0.01% 781
2024
Q4
$231K Buy
+7,362
New +$236K 0.01% 792

Other funds holding FTGS

Geneos Wealth Management's FTGS Position: Q2 2026 in Review

Geneos Wealth Management reduced its First Trust Growth Strength ETF (FTGS) stake by 0.22% in Q2 2026, selling an estimated $1.78K and leaving 22,431 shares worth $830K. The position accounts for 0.02% of the portfolio, ranked #589.

Geneos Wealth Management first reported a position in FTGS in Q4 2024 and has held it in 7 quarters since. 190 funds tracked by Wall St. Rank hold FTGS as of Q2 2026.

  • Geneos Wealth Management held 22,431 shares of First Trust Growth Strength ETF worth $830K as of Q2 2026.
  • Geneos Wealth Management sold 49 First Trust Growth Strength ETF shares in Q2 2026, an estimated $1.78K.
  • First Trust Growth Strength ETF made up 0.02% of Geneos Wealth Management's portfolio in Q2 2026, its #589 holding.
  • Geneos Wealth Management first reported a position in First Trust Growth Strength ETF in Q4 2024 and has held it in 7 quarters since.
  • 190 funds tracked by Wall St. Rank held First Trust Growth Strength ETF as of Q2 2026.

Based on Geneos Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.